the endocrine system.” Endocrine Reviews 26, no. 7 (2005): 944–984.
7. Cooper, Glinda S., and Berrit C. Stroehla. “The epidemiology of autoimmune diseases.” Autoimmunity Reviews 2, no. 3 (2003): 119–125.
8. Fröhlich, Eleonore, and Richard Wahl. “Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra– thyroidal diseases.” Frontiers in Immunology 8 (2017) 521: 1–16.
9. Turker, Omer, Kamil Kumanlioglu, Inanc Karapolat, and Ismail Dogan. “Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses.” Journal of Endocrinology 190, no. 1 (2006): 151–156; Gärtner, Roland, Barbara C.H. Gasnier, Johannes W. Dietrich, Bjarne Krebs, and Matthias W.A. Angstwurm. “Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations.” The Journal of Clinical Endocrinology & Metabolism 87, no. 4 (2002): 1687–1691; Fan, Yaofu, Shuhang Xu, Huifeng Zhang, Wen Cao, Kun Wang, Guofang Chen, Hongjie Di, Meng Cao, and Chao Liu. “Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis.” International Journal of Endocrinology 2014 (2014): 1–8; Xu, Jian, Xue-Feng Yang, Huai-Lan Guo, Xiao-Hui Hou, Lie-Gang Liu, and Xiu-Fa Sun. “Selenium supplement alleviated the toxic effects of excessive iodine in mice.” Biological Trace Element Research 111, no. 1–3 (2006): 229–238; Drutel, Anne, Françoise Archambeaud, and Philippe Caron. “Selenium and the thyroid gland: more good news for clinicians.” Clinical Endocrinology 78, no. 2 (2013): 155–164.
10. Mahmoodianfard, Salma, Mohammadreza Vafa, Fatemeh Golgiri, Mohsen Khoshniat, Mahmoodreza Gohari, Zahra Solati, and Mahmood Djalali. “Effects of zinc and selenium supplementation on thyroid function in overweight and obese hypothyroid female patients: a randomized double-blind controlled trial.” Journal of the American College of Nutrition 34, no. 5 (2015): 391–399.
11. Nishiyama, Soroku, Yoshiko Futagoishi-Suginohara, Makoto Matsukura, Toshiro Nakamura, Akimasa Higashi, Makoto Shinohara, and Ichiro Matsuda. “Zinc supplementation alters thyroid hormone metabolism in disabled patients with zinc deficiency.” Journal of the American College of Nutrition 13, no. 1 (1994): 62–67; Ruz, Manuel, Juana Codoceo, Jose Galgani, Luis Muñoz, Nuri Gras, Santiago Muzzo, Laura Leiva, and Cleofina Bosco. “Single and multiple selenium-zinc-iodine deficiencies affect rat thyroid metabolism and ultrastructure.” The Journal of Nutrition 129, no. 1 (1999): 174–180.
12. Maxwell, Christy, and Stella Lucia Volpe. “Effect of zinc supplementation on thyroid hormone function.” Annals of Nutrition and Metabolism 51, no. 2 (2007): 188–194.
13. Fallah, Soudabeh, Fatemeh Valinejad Sani, and Mohsen Firoozrai. “Effect of contraceptive pill on the selenium and zinc status of healthy subjects.” Contraception 80, no. 1 (2009): 40–43; Hunt, Janet R. “Bioavailability of iron, zinc, and other trace minerals from vegetarian diets.” The American Journal of Clinical Nutrition 78, no. 3 (2003): 633S–639S.
14. Gupta, C.P. “Role of iron (Fe) in body.” IOSR Journal of Applied Chemistry (IOSR-JAC) 7 (2014): 38–46.
15. Takamatsu, J., M. Majima, K. Miki, K. Kuma, and T. Mozai. “Serum ferritin as a marker of thyroid hormone action on peripheral tissues.” The Journal of Clinical Endocrinology and Metabolism 61, no. 4 (1985): 672–676.
16. Sachdeva, Ashuma, Veena Singh, Isha Malik, Prasanta Saha Roy, Himanshu Madaan, and Rajesh Nair. “Association between serum ferritin and thyroid hormone profile in hypothyroidism.” International Journal of Medical Science and Public Health 4, no. 6 (2015): 863–865; Kubota, K., J. Tamura, H. Kurabayashi, T. Shirakura, and I. Kobayashi. “Evaluation of increased serum ferritin levels in patients with hyperthyroidism.” The Clinical Investigator 72, no. 1 (1993): 26–29.
17. Hess, Sonja Y., Michael B. Zimmermann, Myrtha Arnold, Wolfgang Langhans, and Richard F. Hurrell. “Iron deficiency anemia reduces thyroid peroxidase activity in rats.” The Journal of Nutrition 132, no. 7 (2002): 1951–1955; Zimmermann, Michael B. “The influence of iron status on iodine utilization and thyroid function.” Annual Review of Nutrition 26 (2006): 367–389.
18. Martinez-Torres, C., L. Cubeddu, E. Dillmann, G.L. Brengelmann, I. Leets, M. Layrisse, D.G. Johnson, and C. Finch. “Effect of exposure to low temperature on normal and iron-deficient subjects.” The American Journal of Physiology 246, no. 3 (1984): R380–R383; Beard, John L., M.J. Borel, and Janice Derr. “Impaired thermoregulation and thyroid function in iron-deficiency anemia.” The American Journal of Clinical Nutrition 52, no. 5 (1990): 813–819.
19. Beard, John L., M.J. Borel, and Janice Derr. “Impaired thermoregulation and thyroid function in iron-deficiency anemia.” The American Journal of Clinical Nutrition 52, no. 5 (1990): 813–819.
20. Gröber, Uwe, Joachim Schmidt, and Klaus Kisters. “Magnesium in prevention and therapy.” Nutrients 7, no. 9 (2015): 8199–8226.
21. Mazur, Andrzej, Jeanette A.M. Maier, Edmond Rock, Elyett Gueux, Wojciech Nowacki, and Yves Rayssiguier. “Magnesium and the inflammatory response: potential physiopathological implications.” Archives of Biochemistry and Biophysics 458, no. 1 (2007): 48–56; Abbas, Amr M., and Hussein F. Sakr. “Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism.” Canadian Journal of Physiology and Pharmacology 94, no. 4 (2015): 426–432; Moncayo, Roy, and Helga Moncayo. “The WOMED model of benign thyroid disease: acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation.” BBA Clinical 3 (2015): 44–64.
22. Moncayo, Roy, and Helga Moncayo. “Proof of concept of the WOMED model of benign thyroid disease: restitution of thyroid morphology after correction of physical and psychological stressors and magnesium supplementation.” BBA Clinical 3 (2015): 113–122; Moncayo, Roy, and Helga Moncayo. “The WOMED model of benign thyroid disease: acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation.” BBA Clinical 3 (2015): 44–64; Baldini, Marina, Daniela Castagnone, Roberto Rivolta, Laura Meroni, Marco Pappalettera, and Luigi Cantalamessa. “Thyroid vascularization by color doppler ultrasonography in Graves’ disease. Changes related to different phases and to the long-term outcome of the disease.” Thyroid 7, no. 6 (1997): 823–828.
23. Moncayo, Roy, and Helga Moncayo. “The WOMED model of benign thyroid disease: acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation.” BBA Clinical 3 (2015): 44–64; Moncayo, Roy, and Helga Moncayo. “Proof of concept of the WOMED model of benign thyroid disease: restitution of thyroid morphology after correction of physical and psychological stressors and magnesium supplementation.” BBA Clinical 3 (2015): 113–122.
24. Hess, Sonja Y. “The impact of common micronutrient deficiencies on iodine and thyroid metabolism: the evidence from human studies.” Best Practice & Research Clinical Endocrinology & Metabolism 24, no. 1 (2010): 117–132; Oba, Kiyoshi, and Shuichi Kimura. “Effects
